Copyright
©The Author(s) 2021.
World J Orthop. Jun 18, 2021; 12(6): 386-394
Published online Jun 18, 2021. doi: 10.5312/wjo.v12.i6.386
Published online Jun 18, 2021. doi: 10.5312/wjo.v12.i6.386
Table 2 Comparison of outcomes between coronavirus disease 2019 positive and coronavirus disease 2019 negative cohorts
Outcome | Analysis | Negative (n = 146), n (%) | Positive (n = 51), n (%) | Odds ratio2 (95%CI) | P value |
Intensive care | Unadjusted | 8 (5) | 14 (27) | 6.53 (2.55, 16.7) | < 0.001 |
Admission | Adjusted1 | - | - | 4.64 (1.59, 13.5) | 0.005 |
30-d mortality | Unadjusted | 14 (10) | 15 (29) | 3.93 (1.74, 8.89) | 0.001 |
Adjusted1 | - | - | 3.00 (1.22, 7.40) | 0.02 | |
Negative (n = 146), Med [IQR] | Positive (n = 51), Med [IQR] | Hazard ratio2 (95%CI) | |||
Length of stay | Unadjusted | 9 [7, 13] | 23 [19, 31] | 0.28 (0.18, 0.42) | < 0.001 |
(d) | Adjusted1 | - | - | 0.26 (0.17, 0.42) | < 0.001 |
- Citation: Cuthbert R, Ferguson D, Kayani B, Haque S, Ali A, Parkar A, Bates P, Vemulapalli K. Evidence-based approach to providing informed consent for hip fracture surgery during the COVID-19 era. World J Orthop 2021; 12(6): 386-394
- URL: https://www.wjgnet.com/2218-5836/full/v12/i6/386.htm
- DOI: https://dx.doi.org/10.5312/wjo.v12.i6.386